Targeting polycomb-mediated epigenetic silencing in T cell acute lymphoblastic leukemia |
Vanderbilt University Medical Center / Emmanuel Volanakis |
Young Investigator Grants |
2011 |
Tennessee |
Transcriptome Sequencing (RNA-Seq) for Identification of Novel Markers of Disease Outcome and Therapeutic Targets in Acute Myeloid Leukemia |
Fred Hutchinson Cancer Research Center / Fabiana Ostronoff, MD |
Young Investigator Grants |
2012 |
Washington |
Characterization and Targeting of Novel Activating BRAF Mutations in Pediatric Brain Tumors |
Children’s Hospital of Philadelphia / Angela Waanders, MD, MPH |
Young Investigator Grants |
2010 |
Pennsylvania |
Describing the Biological Impacts of Gain-of-function SAMD9 Mutations |
Vanderbilt University Medical Center / Jason Schwartz, MD/PhD |
Young Investigator Grants |
2018 |
Tennessee |
Ca2+ Release Activated Ca2+ (CRAC) Channels in Control of Leukemic Cell Metabolism and Leukemia Stem Cell Maintenance in T-ALL |
New York University School of Medicine / Mate Maus, PhD |
Young Investigator Grants |
2014 |
New York |
MLL Oncogene-Dependent Enhancer Reprogramming Promotes Leukemogenesis |
Stanford University / Feng Pan, PhD |
Young Investigator Grants |
2019 |
California |
Targeting Metabolism as a Therapeutic Approach for High-Risk MYCN-Driven Neuroblastoma |
University of Pennsylvania / Nicole Anderson, PhD |
Young Investigator Grants |
2016 |
Pennsylvania |
MicroRNAs 100 and 125b in Ewing sarcoma |
University of Colorado Denver / Paul Jedlicka |
Young Investigator Grants |
2010 |
Colorado |
Cooperating Signaling Networks Regulate Cell Survival of Pediatric Ph-like ALL |
University of Pennsylvania / Christian Hurtz, PhD |
Young Investigator Grants |
2018 |
Pennsylvania |
Mechanisms of CNOT3 Tumor Suppression in T-ALL and Identification of New Drugs That Specifically Kill CNOT3-Deficient T-ALL Cells |
Dana-Farber Cancer Institute / Zhaodong Li, PhD |
Young Investigator Grants |
2014 |
Massachusetts |